Chat with us, powered by LiveChat Skip to content
SFSBreakthroughDesignation

FDA Grants Breakthrough Device Designation for CurveBeam AI’s OssView™ Bone Fragility Software

<HATFIELD, Penn. -  September 12, 2022>  CurveBeam AI, Ltd announced its medical diagnostic software, OssView™, has received US Food and Drug Administration (FDA) Breakthrough Device Designation. OssView calculates a Structural Fragility Score (SFS), which determines bone microstructural deterioration, a highly…

Read more
Back To Top